References
- Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplifica-tion of the nuc gene. J Clin Microbiol 1992; 30 (7): 1654–1660.
- Perez-Roth E, Claverie-Martin F, Villar J, Mendez-Alvarez S. Multiplex PCR for simultaneous identification of Staphylo- coccus aureus and detection of methicillin and mupirocin resist-ance. J Clin Microbiol 2001; 39 (11): 4037–4041.
- EARSS Management Team. EARSS manual 2005. EARSS Management Team, Bilthoven, The Netherlands 2005; [Online.] http://www.rivm.nl/earss/tools/
- Walsh TR, Blomström A, Qwärnström A, Ho P, Wootton M, Howe RA, et al. Evaluation of current methods for detection of Staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39 (7): 2439–2444.
- Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for the characterization of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) clones of Staphylococcus aureus. J Clin Microbiol 2000; 38 (3): 1008–1015.
- Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Mi-crobiol 2003; 41 (12): 5442-5448.
- Oliveira DC, Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46 (7): 2155–2161.
- EARSS Management Team. EARSS annual reports. EARSS Management Team, Bilthoven, The Netherlands 2001-2006; [Online.] http://www.rivm.nl/earss/database/
- MMR Perdreau-Remington F, Chambers HF. Van-comycin treatment failure associated with heterogeneous van-comycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 2003; 47 (4): 1262–1266.
- Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Ten-over FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40 (1): 135–136.
- Tenover FC, McDonald LC. Vancomycin-resistant staphy-lococci and enterococci: epidemiology and control. Curr Opin Infect Dis 2005; 18 (4): 300–305.
- Yanagihara K, Okada M, Fukuda Y, Imamura Y, Kaneko Y, Ohno H, et al. Efficacy of quinupristin-dalfopristin against me-thicillin-resistant Staphylococcus aureus and vancomycin-insen-sitive S. aureus in a model of hematogenous pulmonary infection. Chemotherapy 2004; 50 (5): 260-264.
- Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. Vancomycin susceptibility within methicillin-resistant Staphylo-coccus aureus lineages. Emerg Infect Dis 2004; 10 (5): 855–857.
- Luczak-Kadlubowska A, Krzyszton-Russjan J, Hryniewicz W. Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins. J Clin Microbiol 2006; 44 (11): 4018–4024.
- Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99 (11): 7687–7692.
- Liu C, Chambers HF. Staphylococcus aureus with het-erogeneous resistance to vancomycin: epidemiology, clinical sig-nificance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47 (10): 3040–3045.
- Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004; 48 (12): 4926–4928.
- Conceigao T, Aires-de-Sousa M, Fäzi M, Tóth A, Pászti J, Ungvári E, et al. Replacement of methicillin-resistant Staphylo-coccus aureus clones in Hungary over time: a 10-year surveil-lance study. Clin Microbiol Infect 2007; 13 (10): 971–979.